Zhang Weijun, Bai Jinwu, Hang Kai, Xu Jianxiang, Zhou Chengwei, Li Lijun, Wang Zhongxiang, Wang Yibo, Wang Kanbin, Xue Deting
Department of Orthopaedics, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
Institute of Orthopaedics, School of Medicine, Zhejiang University, Hangzhou, China.
Front Cell Dev Biol. 2022 Feb 7;10:817877. doi: 10.3389/fcell.2022.817877. eCollection 2022.
Mesenchymal stem cell (MSC) transplantation has been widely used as a potential treatment for a variety of diseases. However, the contradiction between the low survival rate of transplanted cells and the beneficial therapeutic effects has affected its clinical use. Lysosomes as organelles at the center of cellular recycling and metabolic signaling, play essential roles in MSC homeostasis. In the first part of this review, we summarize the role of lysosomal acidification dysfunction in MSC senescence. In the second part, we summarize some of the potential strategies targeting lysosomal proteins to enhance the therapeutic effect of MSCs.
间充质干细胞(MSC)移植已被广泛用作多种疾病的潜在治疗方法。然而,移植细胞低存活率与有益治疗效果之间的矛盾影响了其临床应用。溶酶体作为细胞循环和代谢信号中心的细胞器,在MSC稳态中发挥着重要作用。在本综述的第一部分,我们总结了溶酶体酸化功能障碍在MSC衰老中的作用。在第二部分,我们总结了一些针对溶酶体蛋白以增强MSC治疗效果的潜在策略。